Form 4: PetMed Express Director Batushansky Receives Stock Grant

Director Peter Batushansky received 2,527 restricted stock units from PetMed Express, Inc. on April 9, 2025, which will vest on April 9, 2026, contingent upon continued service on the board.

Summary

• On April 9, 2025, Peter Batushansky, a director of PetMed Express, Inc., was granted 2,527 restricted stock units (RSUs).
• These RSUs were granted under the company's Non-Employee Director Equity Compensation Program.
• The RSUs will vest on April 9, 2026, provided Batushansky continues to serve on the Board of Directors through that date.
• Each RSU represents the right to receive one share of PetMed Express's common stock upon vesting.

Sentiment

Score: 7

Explanation: The document reflects a routine grant of stock to a director, which is generally viewed as a positive sign of aligning interests. There are no indications of negative news or concerns.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Equity compensation is a common practice for compensating board members, aligning their interests with shareholders and incentivizing long-term value creation. This is standard practice across publicly listed companies to attract and retain qualified directors.

Comparison to Industry Standards

• Granting restricted stock units (RSUs) to non-employee directors is a common practice among publicly traded companies to align their interests with shareholders.
• The vesting period of one year is fairly standard, as it encourages continued service on the board.
• Comparable companies in the pet medication and supplies industry, such as Chewy (CHWY) and Zoetis (ZTS), also utilize equity compensation for their directors.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of shareholders, potentially leading to decisions that benefit the company's long-term value.

Key Dates

Keywords

PetMed Express, Director, Restricted Stock Units, RSUs, Equity Compensation, Vesting, Beneficial Ownership, Form 4